Rob Jenq, M.D.
Areas of Research
The Jenq Laboratory examines the impact of the microbiome on cancer treatment, focusing in particular on bone marrow transplantation and cancer immunotherapies. Data from our group and others has demonstrated that the microbiome can be a potent modulator of cancer treatment efficacy and toxicity. Using a multidisciplinary approach that incorporates patient biospecimen collection, microbiome sequencing, computational methods, functional assays and pre-clinical models, we hope to develop and translate strategies to target the microbiome to further increase treatment efficacy while reducing toxicities.